Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-12

Clinical Trial Update: Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial indicates dexamethasone may improve regulatory T cell function in patients with Graves' disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Xiao-Ming Mao | Conditions: Graves' Disease | Phase 1 | Status: COMPLETED